Integral Diagnostics Limited (ASX:IDX)
Australia · Delayed Price · Currency is AUD 2.330
0.00 (0.00%)
Aug 27, 2026, 4:10 PM AEST
Integral Diagnostics Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 788.62 | 627.22 | 469.7 | 440.76 | 360.93 | |
Revenue Growth | 25.73% | 33.54% | 6.57% | 22.12% | 2.92% |
Cost of Revenue | 545.26 | 431.23 | 317.8 | 298.34 | 238.83 |
Gross Profit | 243.36 | 195.98 | 151.9 | 142.43 | 122.1 |
Selling, General & Admin | 41.61 | 33.91 | 25.75 | 23.39 | 21.17 |
Research & Development | 25.81 | 20.41 | 15.42 | 12.94 | - |
Amortization of Goodwill & Intangibles | 34.31 | 25.29 | 18.97 | 18.03 | 16.06 |
Other Operating Expenses | 27.51 | 24.89 | 20.7 | 22.3 | 26.24 |
Operating Expenses | 169.52 | 139.18 | 109.73 | 103.96 | 83.47 |
Operating Income | 73.84 | 56.8 | 42.17 | 38.47 | 38.62 |
Interest Expense | -33.14 | -28.77 | -22.31 | -18.3 | -10.48 |
Interest & Investment Income | 1.26 | 1.09 | 0.86 | 0.42 | 0.04 |
Earnings From Equity Investments | - | - | -0.06 | -0.33 | -0.16 |
Other Non Operating Income (Expenses) | -0.46 | -0.13 | -0.23 | -0.05 | - |
EBT Excluding Unusual Items | 41.5 | 28.98 | 20.42 | 20.22 | 28.02 |
Merger & Restructuring Charges | - | -17.47 | - | 10.41 | -5.46 |
Impairment of Goodwill | - | - | -71.6 | - | - |
Asset Writedown | - | -0.54 | -3.04 | - | - |
Other Unusual Items | -9.51 | -2.91 | -2.92 | - | - |
Pretax Income | 32.11 | 8.82 | -57.14 | 30.63 | 22.56 |
Income Tax Expense | 10.07 | 5.99 | 3.56 | 5.59 | 7.96 |
Earnings From Continuing Operations | 22.04 | 2.84 | -60.7 | 25.04 | 14.6 |
Minority Interest in Earnings | -0.11 | -0.15 | - | - | - |
Net Income | 21.93 | 2.69 | -60.7 | 25.04 | 14.6 |
Net Income to Common | 21.93 | 2.69 | -60.7 | 25.04 | 14.6 |
Net Income Growth | 715.66% | - | - | 71.47% | -53.30% |
Shares Outstanding (Basic) | 373 | 307 | 233 | 233 | 209 |
Shares Outstanding (Diluted) | 377 | 310 | 233 | 236 | 212 |
Shares Change | 21.40% | 32.86% | -0.97% | 11.29% | 5.70% |
EPS (Basic) | 0.06 | 0.01 | -0.26 | 0.11 | 0.07 |
EPS (Diluted) | 0.06 | 0.01 | -0.26 | 0.11 | 0.07 |
EPS Growth | 561.41% | - | - | 53.62% | -55.77% |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | 45.6 | 14.01 | 42.28 | 23.28 | 9.33 |
Free Cash Flow Per Share | 0.12 | 0.04 | 0.18 | 0.10 | 0.04 |
Dividend Per Share | 0.093 | 0.065 | 0.058 | 0.060 | 0.070 |
Dividend Growth | 43.08% | 12.07% | -3.33% | -14.29% | -44.00% |
Gross Margin | 30.86% | 31.25% | 32.34% | 32.31% | 33.83% |
Operating Margin | 9.36% | 9.06% | 8.98% | 8.73% | 10.70% |
Profit Margin | 2.78% | 0.43% | -12.92% | 5.68% | 4.05% |
Free Cash Flow Margin | 5.78% | 2.23% | 9.00% | 5.28% | 2.58% |
EBITDA | 112.39 | 87.7 | 66.22 | 66.08 | 62.22 |
EBITDA Margin | 14.25% | 13.98% | 14.10% | 14.99% | 17.24% |
D&A For EBITDA | 38.55 | 30.9 | 24.05 | 27.61 | 23.6 |
EBIT | 73.84 | 56.8 | 42.17 | 38.47 | 38.62 |
EBIT Margin | 9.36% | 9.06% | 8.98% | 8.73% | 10.70% |
Effective Tax Rate | 31.36% | 67.86% | - | 18.26% | 35.27% |
Revenue as Reported | 790 | 629.06 | 470.56 | 441.21 | 360.97 |